Limitations, agreements, and source contact

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate · Source last updated 2022-01-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

hkantarjian@mdanderson.org

organization

University of Texas (UT) MD Anderson Cancer Center

phone

(713) 792-7026

title

Hagop M Kantarjian,MD/Chair, Leukemia

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice